These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 21402342)

  • 21. GAP-134 ([2S,4R]-1-[2-aminoacetyl]4-benzamidopyrrolidine-2-carboxylic acid) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
    Hennan JK; Swillo RE; Morgan GA; Rossman EI; Kantrowitz J; Butera J; Petersen JS; Gardell SJ; Vlasuk GP
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):207-14. PubMed ID: 19721133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
    Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
    Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of estrogen replacement therapy on ventricular repolarization dynamics in healthy postmenopausal women.
    Vrtovec B; Starc V; Meden-Vrtovec H
    J Electrocardiol; 2001 Oct; 34(4):277-83. PubMed ID: 11590553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular arrhythmias.
    Mahla E; Metzler H
    Acta Anaesthesiol Scand Suppl; 1997; 111():27-8. PubMed ID: 9420943
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mean frequency of premature ventricular complexes as predictor of malignant ventricular arrhythmias.
    Carrim ZI; Khan AA
    Mt Sinai J Med; 2005 Nov; 72(6):374-80. PubMed ID: 16358161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
    de Kraker AT; Kenemans P; Smolders RG; Kroeks MV; van der Mooren MJ
    Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):139-44. PubMed ID: 19095343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden death in a patient with idiopathic right ventricular outflow tract arrhythmia.
    Bottoni N; Quartieri F; Lolli G; Iori M; Manari A; Menozzi C
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):801-3. PubMed ID: 19584742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
    Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
    Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ventricular extrasystole in comparison with manifestations of ventricular tachycardia and ventricular fibrillation in acute myocardial infarct]].
    Jug M; Batinić Z; Goldner V; Delimar N
    Lijec Vjesn; 1995; 117(3-4):68-72. PubMed ID: 8538355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.
    Vogelvang TE; Mijatovic V; Kenemans P; Schalkwijk CG; van der Mooren MJ
    Am J Cardiol; 2004 Nov; 94(9):1205-8. PubMed ID: 15518626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case 6: ventricular arrhythmias after acute myocardial infarction.
    Dhanekula L; Olshansky B; Ornato JP; Friedewald VE
    Am J Cardiol; 2000 Apr; 85(8):1041. PubMed ID: 10877723
    [No Abstract]   [Full Text] [Related]  

  • 36. The "nervous" kidney and ventricular fibrillation: a possible game changer?
    Karagueuzian HS
    Heart Rhythm; 2013 Oct; 10(10):1531-2. PubMed ID: 23872697
    [No Abstract]   [Full Text] [Related]  

  • 37. Ventricular arrhythmia: a new explanation for hemoglobin paradox in end-stage renal disease?
    Chao CT
    Hemodial Int; 2011 Oct; 15(4):581-2. PubMed ID: 22111830
    [No Abstract]   [Full Text] [Related]  

  • 38. Peripheral thyroid hormone metabolism in patients with complex ventricular arrhythmias.
    Biagini A; Iervasi G; Clerico A; Berti S; Pilo A; Vitek F; Rita B; Bianchi R; Donato L
    Am J Cardiol; 1995 Mar; 75(8):630-3. PubMed ID: 7887396
    [No Abstract]   [Full Text] [Related]  

  • 39. When should postmenopausal women start taking oestrogen replacement therapy?
    Prince RL; Geelhoed EA
    Med J Aust; 1995 Feb; 162(4):173-4. PubMed ID: 7877535
    [No Abstract]   [Full Text] [Related]  

  • 40. Redefining Optimal Targets for Intramural Ventricular Arrhythmias: Planning for Combat!
    Bradfield JS
    JACC Clin Electrophysiol; 2020 Oct; 6(11):1349-1352. PubMed ID: 33121662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.